Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: LUF6283
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

92933-48-7

92933-48-7 structure
92933-48-7 structure
  • Name: LUF 6283
  • Chemical Name: 5-Butyl-1H-pyrazole-3-carboxylic acid
  • CAS Number: 92933-48-7
  • Molecular Formula: C8H12N2O2
  • Molecular Weight: 168.19300
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage PERK
  • Create Date: 2016-01-06 03:16:02
  • Modify Date: 2024-01-04 08:09:45
  • LUF6283 is a potent and orally active HCA(2) partial agonist, with a Ki of 0.55 µM. LUF6283 can achieve the beneficial lipid lowering effect of niacin without producing the unwanted cutaneous flushing side effect[1].

Name 5-Butyl-1H-pyrazole-3-carboxylic acid
Synonyms 5-butyl-[1,3,5]triazinane-2-thione
Dihydrokainic acid
5-Butyl-1(2)H-pyrazol-3-carbonsaeure
5-Butyl-tetrahydro-s-triazin-2(1H)-thion
5-butyl-1,4,5,6-tetrahydro-1,3,5-triazine-2-thiol
1-Butyl-hexahydrotriazinthion-4
5-butyl-1(2)H-pyrazole-3-carboxylic acid
Description LUF6283 is a potent and orally active HCA(2) partial agonist, with a Ki of 0.55 µM. LUF6283 can achieve the beneficial lipid lowering effect of niacin without producing the unwanted cutaneous flushing side effect[1].
Related Catalog
Target

EC50: 0.32 ± 0.06 μM (pERK1/2)[1]

In Vivo LUF6283 (C57BL/6 mice, 400 mg/kg, Oral gavage, once a day for 4 weeks) has no effect on adipose tissue ATGL/HSL expression, and significantly reduces the expression of apolipoprotein B (APOB)[1].
References

[1]. Li Z, et al. Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice. Br J Pharmacol. 2012 Oct;167(4):818-25.

Molecular Formula C8H12N2O2
Molecular Weight 168.19300
Exact Mass 168.09000
PSA 65.98000
LogP 1.45050
RIDADR NONH for all modes of transport

~69%

92933-48-7 structure

92933-48-7

Literature: Seki; Isegawa; Fukuda; Ohki Chemical and Pharmaceutical Bulletin, 1984 , vol. 32, # 4 p. 1568 - 1577

~%

92933-48-7 structure

92933-48-7

Literature: Van Herk; Brussee; Van den Nieuwendijk; Van der Klein; IJzerman; Stannek; Burmeister; Lorenzen Journal of Medicinal Chemistry, 2003 , vol. 46, # 18 p. 3945 - 3951

~%

92933-48-7 structure

92933-48-7

Literature: Lehninger Journal of Biological Chemistry, 1944 , vol. 153, p. 564

~%

92933-48-7 structure

92933-48-7

Literature: Lehninger Journal of Biological Chemistry, 1944 , vol. 153, p. 564